Continuing Pharm Exec editor Patrick Clinton’s conversation with Bill Trombetta on the top four pharma companies and what makes them special.
Eli Lilly: With double-digit growth in sales, and a solid improvement in revenue per employee, Lilly placed fourth in the Company of the Year rundown. Bill Trombetta explains Lilly’s position as a big/small pharma and maps out the challenges that lie ahead for Lilly.
PharmExec Blog
Follow Us
RSS
Bookstore
Pharm Exec Podcast Series:
Bill Trombetta Industry Audit (Part 2)
Eli Lilly: With double-digit growth in sales, and a solid improvement in revenue per employee, Lilly placed fourth in the Company of the Year rundown. Bill Trombetta explains Lilly’s position as a big/small pharma and maps out the challenges that lie ahead for Lilly.